Vimarsana
Biggest News Aggregation in the World

Page 3 - Mouse Models News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mouse Models. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mouse Models Today - Breaking & Trending Today

Local notes: OLLI visits museum; Fenix names director - Vimarsana News

Local notes: OLLI visits museum; Fenix names director

Boys & Girls Club

Tonix Pharmaceuticals Presents New Preclinical Data at Seventh International Cancer Immunotherapy Conference 2023 - Vimarsana News

Tonix Pharmaceuticals Presents New Preclinical Data at Seventh International Cancer Immunotherapy Conference 2023

MTNX-1700 (mTFF2-MSA) suppresses tumor growth and increases survival rates in preclinical colorectal cancer models mTNX-1700 shows single agent activity and additive effects in combination with anti-PD-1 mTNX-1700 targets myeloid-derived suppressor cells (MDSCs) in a novel mechanism to treat cancer CHATHAM, N.J., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a biopharmaceutical company with marketed products and a pipeline of development candidates, today

Source: yahoo.com
Local Notes: open mic poetry, party in the park friendraiser and Mayor's Youth Academy ahead - Vimarsana News

Local Notes: open mic poetry, party in the park friendraiser and Mayor's Youth Academy ahead

Blood Drive

Women's Giving Circle Awards $110,000 in Funding to U of A Programs - Vimarsana News

Women's Giving Circle Awards $110,000 in Funding to U of A Programs

Nine university programs were awarded a combined $110,000 from the Women’s Giving Circle.

Source: uark.edu
Bloomsbury Genetic Therapies Receives Rare Pediatric Disease Designation from the U.S. FDA for BGT-NPC for the Treatment of Niemann-Pick Disease Type C (NPC) - Vimarsana News

Bloomsbury Genetic Therapies Receives Rare Pediatric Disease Designation from the U.S. FDA for BGT-NPC for the Treatment of Niemann-Pick Disease Type C (NPC)

Bloomsbury Genetic Therapies Limited, a clinical-stage biotechnology company developing potentially curative treatments for patients suffering from rare neurological and metabolic diseases based on clinically proven gene therapy technologies, announced today that the U.S. Food and Drug Administration (FDA) has ...